Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough

被引:23
|
作者
Page-Shafer, Kimberly [1 ]
Hahn, Judith A. [1 ]
Lum, Paula J. [1 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94080 USA
关键词
D O I
10.1097/QAD.0b013e3282ef7701
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1967 / 1969
页数:3
相关论文
共 50 条
  • [31] Hepatitis C Virus Infection among Injection Drug Users with and without Human Immunodeficiency Virus Co-Infection
    Hsieh, Meng-Hsuan
    Tsai, Jih-Jin
    Hsieh, Ming-Yen
    Huang, Chung-Feng
    Yeh, Ming-Lun
    Yang, Jeng-Fu
    Chang, Ko
    Lin, Wei-Ru
    Lin, Chun-Yu
    Chen, Tun-Chieh
    Huang, Jee-Fu
    Dai, Chia-Yen
    Yu, Ming-Lung
    Chuang, Wan-Long
    [J]. PLOS ONE, 2014, 9 (04):
  • [32] A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users
    Garfein, Richard S.
    Golub, Elizabeth T.
    Greenberg, Alan E.
    Hagan, Holly
    Hanson, Debra L.
    Hudson, Sharon M.
    Kapadia, Farzana
    Latka, Mary H.
    Ouellet, Lawrence.
    Purcell, David W.
    Strathdee, Steffanie A.
    Thiede, Hanne
    [J]. AIDS, 2007, 21 (14) : 1923 - 1932
  • [33] Epidemiology and natural history of hepatitis C virus infection in injection drug users: Implications for treatment
    Sulkowski, MS
    Thomas, DL
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 : S263 - S269
  • [34] Prevalence and incidence of hepatitis C virus infection among young adult injection drug users
    Garfein, RS
    Doherty, MC
    Monterroso, ER
    Thomas, DL
    Nelson, KE
    Vlahov, D
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 18 : S11 - S19
  • [35] Hepatitis C virus infection among injection drug users - Survival analysis of time to seroconversion
    Hagan, H
    Thiede, H
    Des Jarlais, DC
    [J]. EPIDEMIOLOGY, 2004, 15 (05) : 543 - 549
  • [36] Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users
    Backmund, M
    Meyer, K
    Edlin, BR
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (10) : 1540 - 1543
  • [37] INFLUENCE OF F PROTEIN ON OUTCOME OF HEPATITIS C VIRUS INFECTION AMONG INJECTION DRUG USERS
    Wang Jie
    Zhang Yun
    Yang Jingjing
    Deng Xiaozhao
    Cao Min
    Yu Rongbin
    Xu Ke
    Wang Haopeng
    [J]. PROGRESS ON POST-GENOME TECHNOLOGIES AND MODERN NATURAL PRODUCTS, 2011, 2011, : 415 - 418
  • [38] GB virus C infection among young, HIV-negative injection drug users with and without hepatitis C virus infection
    Boodram, B.
    Hershow, R. C.
    Klinzman, D.
    Stapleton, J. T.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2011, 18 (04) : e153 - e159
  • [39] Not all injection drug users are created equal: Heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia
    Kuniholm, Mark H.
    Aladashvili, Malvina
    Del Rio, Carlos
    Stvilia, Ketavan
    Gabelia, Nino
    Chitale, Rohit A.
    Tsertsvadze, Tengiz
    Nelson, Kenrad E.
    [J]. SUBSTANCE USE & MISUSE, 2008, 43 (10) : 1424 - 1437
  • [40] Hepatitis C virus infection among Alaskan drug users
    Fisher, DG
    Fenaughty, AM
    Paschane, AA
    Paschane, DM
    Cagle, HH
    Orr, SM
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1997, 87 (10) : 1722 - 1724